TY - JOUR
T1 - Implanted medical devices in the radiation environment of commercial spaceflight
AU - Reyes, David P.
AU - McClure, Steven S.
AU - Chancellor, Jeffery C.
AU - Blue, Rebecca S.
AU - Castleberry, Tarah L.
AU - Vanderploeg, James M.
N1 - Publisher Copyright:
© by the Aerospace Medical Association, Alexandria, VA.
PY - 2014
Y1 - 2014
N2 - Introduction: Some commercial spaceflight participants (SFPs) may have medical conditions that require implanted medical devices (IMDs), such as cardiac pacemakers, defibrillators, insulin pumps, or similar electronic devices. The effect of space radiation on the function of IMDs is unknown. This review will identify known effects of terrestrial and aviation electromagnetic interference (EMI) and radiation on IMDs in order to provide insight into the potential effects of radiation exposures in the space environment. Methods: A systematic literature review was conducted on available literature on human studies involving the effects of EMI as well as diagnostic and therapeutic radiation on IMDs. Results: The literature review identified potential transient effects from EMI and diagnostic radiation levels as low as 10 mGy on IMDs. High-energy, therapeutic, ionizing radiation can cause more permanent device malfunctions at doses as low as 40 mGy. Radiation doses from suborbital flight altitudes and durations are anticipated to be less than those experienced during an average round-trip, cross-country airline flight and are unlikely to result in significant detriment, though longer, orbital flights may expose SFPs to doses potentially harmful to IMD function. Discussion: Individuals with IMDs should experience few, if any, radiation-related device malfunctions during suborbital flight, but could have problems with radiation exposures associated with longer, orbital flights.
AB - Introduction: Some commercial spaceflight participants (SFPs) may have medical conditions that require implanted medical devices (IMDs), such as cardiac pacemakers, defibrillators, insulin pumps, or similar electronic devices. The effect of space radiation on the function of IMDs is unknown. This review will identify known effects of terrestrial and aviation electromagnetic interference (EMI) and radiation on IMDs in order to provide insight into the potential effects of radiation exposures in the space environment. Methods: A systematic literature review was conducted on available literature on human studies involving the effects of EMI as well as diagnostic and therapeutic radiation on IMDs. Results: The literature review identified potential transient effects from EMI and diagnostic radiation levels as low as 10 mGy on IMDs. High-energy, therapeutic, ionizing radiation can cause more permanent device malfunctions at doses as low as 40 mGy. Radiation doses from suborbital flight altitudes and durations are anticipated to be less than those experienced during an average round-trip, cross-country airline flight and are unlikely to result in significant detriment, though longer, orbital flights may expose SFPs to doses potentially harmful to IMD function. Discussion: Individuals with IMDs should experience few, if any, radiation-related device malfunctions during suborbital flight, but could have problems with radiation exposures associated with longer, orbital flights.
KW - Commercial spaceflight participant
KW - Defibrillator
KW - Electromagnetic interference
KW - Ionizing radiation
KW - Neurostimulator
KW - Pacemaker
UR - http://www.scopus.com/inward/record.url?scp=84910079484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84910079484&partnerID=8YFLogxK
U2 - 10.3357/ASEM.4104.2014
DO - 10.3357/ASEM.4104.2014
M3 - Review article
C2 - 25329943
AN - SCOPUS:84910079484
SN - 0095-6562
VL - 85
SP - 1106
EP - 1113
JO - Aviation Space and Environmental Medicine
JF - Aviation Space and Environmental Medicine
IS - 11
ER -